Appointments and Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Contact us
Find Clinical Trials

We sponsor and collaborate on clinical trials that break new ground in pediatric cancer and blood disorder treatment. 

Search Pediatric Cancer and Blood Disorder Clinical Trials
Our Affiliations
HMS Affiliate

Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.

Our Affiliations

Hesham Elhalawani, MD, MSc

  • Instructor in Radiation Oncology, Harvard Medical School
  • Director, Pediatric Radiation Oncology

Appointment Phone

  • 617-732-8783


  • 617-394-2668


Treatment Centers


Clinical Interests

Brain tumors, Image-guided cancer treatments, Machine learning and imaging informatics, Pediatric cancers, Stereotactic radiosurgery




  • Brigham and Women's Hospital/Dana-Farber Cancer Institute, 2022
  • Cleveland Clinic, Taussig Cancer Institute, 2020
  • The University of Texas MD Anderson Cancer Center, 2019


  • Ain Shams University, 2015

Medical School

  • Ain Shams University, 2011


Dr. Elhalawani is an Attending Physician in the Department of Radiation Oncology and Instructor in Radiation Oncology at Harvard Medical School. He completed medical school, internship and residency at Ain Shams University in Cairo, Egypt, followed by a research fellowship in radiation oncology at the University of Texas MD Anderson Cancer Center, and clinical fellowships in radiation oncology at the Cleveland Clinic and the Dana-Farber Brigham Cancer Center. Dr. Elhalawani’s clinical focus is on cancers affecting pediatric patients. He directs his research efforts toward leveraging machine learning and imaging informatics to personalize care for cancer patients. He has a particular interest in integrating multi-parametric magnetic resonance imaging (mpMRI) and quantitative imaging analytics to advance image-guided cancer treatment and surveillance, and has led efforts to develop clinical applications of radiomics analytics in radiation oncology.